Landin Boring focuses his practice on patent acquisition and counseling in the Chemical & Life Sciences industry area. He prosecutes patents for clients in the U.S. and abroad and provides patentability, patent validity, infringement, and freedom-to-operate counseling to assist clients in business planning.
Dr. Boring has experience in several technical and legal areas, including molecular biology, antibody technologies, CRISPR/Cas and related gene-editing technologies, immunology, diagnostics, microarrays, biomarkers, small molecule therapeutics, and medical devices.
Before practicing law, Dr. Boring was a post-doctoral fellow with Bristol-Myers Squibb Pharmaceutical Research Institute in Seattle, a staff research investigator with the Gladstone Institutes in San Francisco, and a molecular biology group leader at Xenogen Biosciences in Cranbury, New Jersey.
Dr. Boring was recognized as a 2014 Northern California "Rising Star" in the area of Intellectual Property by Super Lawyers magazine. He was also selected as a 2010 Washington "Rising Star" by Super Lawyers magazine.
University of Washington School of Law J.D. (2007)
University of Washington Ph.D. (1990) Molecular Genetics
University of Washington B.A. (1984) Zoology, cum laude
U.S. Patent and Trademark Office
American Intellectual Property Law Association, Member
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.